Skip to content

Clinical trials

Phase 4 Hypertension trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 4 Country / region: United Kingdom Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20032
20041
20061
20081
20094
20121
20142
20151
20161
20171
20201
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status4
Not yet recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cambridge University Hospitals NHS Foundation Trust2
Imperial College London2
Novartis2
University of Cambridge2
Bayer1
Boehringer Ingelheim1
Bristol-Myers Squibb1
NHS Greater Glasgow and Clyde1
Neil Sulke1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension19
Cardiovascular Diseases3
Essential Hypertension2
Albuminuria1
Atrial Fibrillation1
Cicatrix1
Hypertrophy1
Hypertrophy, Left Ventricular1
Metabolic Syndrome1
Stroke1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.